Skip to main content Help with accessibility Skip to main navigation

Recommendations

This section contains a list of the policy recommendations of the Pan Mersey Area Prescribing Committee.

Reviews of the new medicines have been conducted by our pharmacists using a number of resources including National Institute for Health and Clinical Excellence (NICE) which is a Special health Authority (SHA) set up in 1999. It is used to give advice to the NHS on best clinical practice including the clinical and cost effectiveness of drugs and other treatments.

Definitions and criteria for the categorisation of medicines

Legacy Merseyside
New Cheshire and Merseyside

Transition of Commissioning Policies

On 1st July 2022 NHS Cheshire and Merseyside Integrated Care Board (ICB) became the new statutory body responsible for ensuring health care services are available to meet the reasonable needs of the people of Cheshire & Merseyside.

Until such time as a single suite of commissioning policies can be developed and adopted, NHS Cheshire and Merseyside will continue to adopt and operate the CCG policies it has inherited at Place/borough level, which means that there will be no immediate change in commissioning policy for local people resident in those Places/boroughs from what was in place prior to 1st July 2022.

NHS Cheshire and Merseyside Commissioning Policies

 

Documents

Green
EMPAGLIFLOZIN, ERTUGLIFLOZIN, CANAGLIFLOZIN, and DAPAGLIFLOZIN as MONOTHERAPIES in type 2 diabetes: a multiple prescribing statement
Ha
Kn
Li
SF
SS
SH
Wa
WL
Wi
Date Added: 23 - Sep - 2021

The Pan Mersey Area Prescribing Committee recommends the prescribing ofCANAGLIFLOZIN, DAPAGLIFLOZIN, EMPAGLIFLOZIN and ERTUGLIFLOZIN as
MONOTHERAPIES as options for treating type 2 diabetes in adults in accordance with NICE TA390 and TA572.

Static

Body System:
Green
EMPAGLIFLOZIN, ERTUGLIFLOZIN, CANAGLIFLOZIN, and DAPAGLIFLOZIN, as COMBINATION THERAPIES in type 2 diabetes: a multiple prescribing statement
Ha
Kn
Li
SF
SS
SH
Wa
WL
Wi
Date Added: 23 - Sep - 2021

The Pan Mersey Area Prescribing Committee recommends the prescribing of CANAGLIFLOZIN, DAPAGLIFLOZIN, EMPAGLIFLOZIN and ERTUGLIFLOZIN as COMBINATION THERAPIES as options for treating type 2 diabetes in adults in accordance with NICE guidance.

Static

Body System:
Green
ERTUGLIFLOZIN, CANAGLIFLOZIN, DAPAGLIFLOZIN, and EMPAGLIFLOZIN as COMBINATION THERAPIES in type 2 diabetes: a multiple prescribing statement
Ha
Kn
Li
SF
SS
SH
Wa
WL
Wi
Date Added: 23 - Sep - 2021

The Pan Mersey Area Prescribing Committee recommends the prescribing of CANAGLIFLOZIN, DAPAGLIFLOZIN, EMPAGLIFLOZIN and ERTUGLIFLOZIN as COMBINATION THERAPIES as options for treating type 2 diabetes in adults in accordance with NICE guidance.

Static

Body System:
Green
ERTUGLIFLOZIN, CANAGLIFLOZIN, DAPAGLIFLOZIN, and EMPAGLIFLOZIN as MONOTHERAPIES in type 2 diabetes: a multiple prescribing statement
Ha
Kn
Li
SF
SS
SH
Wa
WL
Wi
Date Added: 23 - Sep - 2021

The Pan Mersey Area Prescribing Committee recommends the prescribing ofCANAGLIFLOZIN, DAPAGLIFLOZIN, EMPAGLIFLOZIN and ERTUGLIFLOZIN as
MONOTHERAPIES as options for treating type 2 diabetes in adults in accordance with NICE TA390 and TA572.

Static

Body System:
Grey
ESTRADIOL 1mg / PROGESTERONE 100mg capsules (Bijuve®) for oestrogen deficiency symptoms in postmenopausal women
Ha
Kn
Li
SF
SS
SH
Wa
WL
Wi
Date Added: 21 - Oct - 2021

The Pan Mersey Area Prescribing Committee does not currently recommend the prescribing of ESTRADIOL / PROGESTERONE capsules (Bijuve®) for oestrogen deficiency symptoms in postmenopausal women.

Body System: